Mi-hua F. Tao
TPQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 51 publications
Development of a novel hemophilia A mouse model to study emicizumab and factor VIII inhibitor risk.
Journal: Blood advances
Published: October 07, 2025
Development of a Novel Hemophilia A Mouse Model to Study Emicizumab and Factor VIII Inhibitor Risk.
Journal: Blood advances
Published: October 07, 2025
AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 27, 2025
Enhancement of adult liver regeneration in mice through the hepsin-mediated epidermal growth factor receptor signaling pathway.
Journal: Communications biology
Published: April 04, 2024
Improvement of Gene Delivery by Minimal Bacteriophage Particles.
Journal: ACS nano
Published: July 19, 2023
Major HBV splice variant encoding a novel protein important for infection.
Journal: Journal of hepatology
Published: July 04, 2023
Recapitulating the immune system of hemophilia A patients with inhibitors using immunodeficient mice.
Journal: Thrombosis research
Published: May 24, 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 04, 2023
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.
Journal: Emerging microbes & infections
Published: November 17, 2022
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.
Journal: Journal of medical virology
Published: August 29, 2022
An efficient approach for SARS-CoV-2 monoclonal antibody production via modified mRNA-LNP immunization.
Journal: International journal of pharmaceutics
Published: June 02, 2022
Last Updated: 09/26/2026